Tokyo extended gains in the week ended May 5 (three trading days only because April 29 and May 5 were national holidays in Japan). The Nikkei 225 finished 1.1% higher, to close at the 14,000 level, a four-month high, while the Topix index rose 1.2%. Investors were encouraged by the weaker yen against the US dollar and the solid performance of New York markets with the recognition that interest cuts by the Federal Reserve Board are likely to pause in the near term. High technology issues and financial stocks drew buying attention. However, the overall market was rather directionless because of the string of "Golden Week" holidays and forthcoming earnings reports after these. The pharmaceutical index inched up 0.3%, underperforming the market.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze